Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genpharmasec Limited has informed the stock exchanges that its trading window will be closed starting Wednesday, April 01, 2026, until 48 hours after the declaration of its Audited Financial Results for the quarter and financial year ended March 31, 2026. During this period, all promoters, directors, key managerial personnel, designated persons, connected persons, and their immediate relatives are prohibited from trading in the company's securities. This is a routine compliance measure under SEBI's Insider Trading Regulations ahead of the annual financial results announcement. The date of the board meeting to approve these results will be communicated separately.
This is a standard regulatory disclosure and does not materially affect shareholders. The window closure is a routine compliance step to prevent insider trading ahead of audited results and signals that the FY26 earnings announcement is expected shortly after April 1, 2026.